Remove 2006 Remove Leads Remove Pharma
article thumbnail

Chiesi expands rare disease portfolio with Amryt Pharma acquisition

pharmaphorum

is to acquire the 2015-established Amryt Pharma Plc. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Biopharma and healthcare group Chiesi Farmaceutici S.p.A. on 6 th January.

Pharma 98
article thumbnail

Drug pricing increases are disgraceful

World of DTC Marketing

Pharma companies continue to be among the most profitable industries, even outperforming tech companies. The Pharma Spin. Pharma continues to spin the lie about the high development costs of drugs but an analysis tells us the truth. This is an industry that doesn’t care about what people think of them.

Insurance 181
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Making an Impact During Disease Awareness Days, Weeks, and Months

PM360

Pharma marketers often turn to disease awareness days, weeks, and months to inform campaigns as they strategize for the year ahead. To the pharma marketing industry, these days and months present a clear opportunity to shed light on a particular condition or therapeutic area. Where Should Pharma Marketers Begin?

Media 92
article thumbnail

The Evolution of Biosimilars from Their Beginning Until Now—And What’s Next

PM360

Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar being approved in Europe in 2006. he is responsible for leading the commercialization efforts of specialty products which includes a broad portfolio of biosimilars. Now, as the President of Accord BioPharma , the U.S.

article thumbnail

Market outlook to 2032: future trends across the seven major markets

European Pharmaceutical Review

billion by 2023, driven by the launch of Merck’s Belsomra and Eisai’s lemborexant (E-2006). GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. million in sales by 2032. million in sales by 2032.

article thumbnail

What Is Influencer Marketing & Is it Safe for Healthcare?

Healthcare Success

Find out in our latest podcast featuring Danielle Wiley, CEO of Sway Group, a leading influencer marketing agency. I don't know if you remember this, Danielle, but there was a book called Here Comes Everybody that came out, probably around 2006, 2008, and it talked about exactly something you just mentioned there, which is that?

Marketing 108
article thumbnail

Top 25 Healthcare Market Research Companies in the USA

Medico Reach

The company specializes in many different areas of the healthcare sector, such as biotech, pharma, etc. via their industry-leading illustration technology and analytics. Mindspot Research has been an expert in online market research since 2006. So, let’s get started. Lucid Health. Applied Marketing Science (AMS).